![](/img/cover-not-exists.png)
A pilot study of cyclophosphamide, carboplatin, etoposide (CCE), and G-CSF with or without rituximab for cytoreduction and peripheral blood stem cell mobilization in patients with relapsed or refractory lymphomas
D.E. Stevenson, A.L. Haroff, D.W. Ririe, J.E. Splichal, D.L. Ornstein, B.J. HellerVolume:
12
Year:
2006
Language:
english
DOI:
10.1016/j.bbmt.2005.11.372
File:
PDF, 60 KB
english, 2006